We serve Ethyl formate CAS:109-94-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Ethyl formate
CAS.NO:109-94-4
Synonyms:
ETHYL FORMATE FOR PHARMA SYNTHESIS
Formic Acid Ethyl Ester
Ethyl Formate, Reagent
Ethyl formate,AcroSeal,Extra Dry
Ethyl formic ester
ETHYL FORMATE/FORMIC ACID ETHYL ESTER
Formic acid, ethyl ester
ethyl ortho-formate
Aethylformiat
Ethylformate
Ethyl formate
ETHYL FORMATE BAKER ANALYZED REAGENT-500 ML
Molecular Formula:C3H6O2
Molecular Weight:74.07850
Physical and Chemical Properties:
Density: 0.921 g / mL at 20 ° C (lit.)
Boiling point: 52-54 ° C (lit.)
Melting point: −80 ° C (lit.)
Flash point: 7 ° F
Refractive index: n20 / D 1.359 (lit.)
Specification:
Appearance:Clear colorless liquid
Purity:≥99.0%
Ethanol: ≤0.50%
Water: ≤0.1%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep away from heat, sparks, and flame. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area.
Application:
It is a solvent for nitrocellulose and cellulose acetate. It is used as an intermediate for uracil, cytosine, and thymine in medicine. It is used as a bactericide in tobacco, cereals, and sorghum.
Contact us for information like Ethyl formate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ETHYL FORMATE BAKER ANALYZED REAGENT-500 ML physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl formate,AcroSeal,Extra Dry Use and application,ETHYL FORMATE/FORMIC ACID ETHYL ESTER technical grade,usp/ep/jp grade.
Related News: There’s still a lot we don’t know about the coronavirus, and scientists internationally are racing to gather data and develop a treatment.ethyl 4-isothiocyanatobenzoate manufacturer Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.Propanedinitrile, 2-[methoxy(4-phenoxyphenyl)methylene]- supplier After testing, our quality assurance staff confirms that everything has been performed correctly in accordance with GMP from manufacturing of API to quality testing.N-[3-[1-(dimethylamino)-3-oxoprop-1-en-2-yl]phenyl]acetamide vendor Since the listing of high-barrier generic drugs involves quickly bypassing or challenging process patents of original research products within a short period of time, API companies play an important role in the process of marketing and sales of generic drugs.This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.
